Novaliq GmbH

Industry · 13 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Recruiting	Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis Non-infectious Anterior Uveitis	Phase 2	2026-03-16
Completed	A Clinical Trial to Evaluate the Corneal Endothelial Health of DED Subjects Treated With Cyclosporine Dry Eye Disease	Phase 4	2024-04-22
Completed	CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease in Subjects Who Completed CYS-004 Dry Eye Disease (DED)	Phase 3	2021-01-04
Completed	ESSENCE 2: CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED) Dry Eye Disease	Phase 3	2020-12-05
Completed	Safety and Efficacy of NovaTears® + Omega-3 (0.2%) Eye Drops on Signs and Symptoms of Dry Eye Evaporative Dry Eye Disease	—	2020-11-09
Completed	Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED) Dry Eye Disease (DED)	Phase 2	2018-01-03
Completed	CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED) Dry Eye Disease	Phase 2 / Phase 3	2017-10-19
Completed	Influence of Perfluorohexyloctane (NovaTears) on Tear Film Thickness in Patients With Mild to Moderate Dry Eye Dry Eye Disease	N/A	2016-12-15
Completed	CyclASol for the Treatment of Moderate to Severe Dry-eye Disease (DED) Dry Eye Syndromes	Phase 2	2016-01-01
Completed	NovaTears® Eye Drops Observational Study NT-002 Dry Eye Syndromes	—	2015-01-01
Completed	NovaTears® Eye Drops Observational Study NT-003 Dry Eye Syndromes	—	2015-01-01
Completed	CyclASol® Phase 1 Study Healthy	Phase 1	2014-03-01
Completed	NovaTears® Eye Drops Observational Study Dry Eye Disease	—	2013-12-01